EGFR as a prognostic biomarker and therapeutic target in ovarian cancer: evaluation of patient cohort and literature review

BACKGROUND: Limited effectiveness of therapeutic agents targeting epidermal growth factor receptor (EGFR) in clinical trials using unselected ovarian cancer patients has prompted efforts to more effectively stratify patients who might best benefit from these therapies. A series of studies that have...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Genes Cancer
Autors principals: Mehner, Christine, Oberg, Ann L., Goergen, Krista M., Kalli, Kimberly R., Maurer, Matthew J., Nassar, Aziza, Goode, Ellen L., Keeney, Gary L., Jatoi, Aminah, Radisky, Derek C., Radisky, Evette S.
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2017
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5511892/
https://ncbi.nlm.nih.gov/pubmed/28740577
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/genesandcancer.142
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars